Pituitary adenylate cyclase-activating polypeptide is protective against oxidative stress in human retinal pigment epithelial cells

Laszlo Mester, Krisztina Kovacs, B. Rácz, Izabella Solti, Tamas Atlasz, K. Szabadfi, A. Tamás, D. Reglodi

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Pituitary adenylate cyclase-activating polypeptide (PACAP) is a neuropeptide with potent neurotrophic and neuroprotective effects. We have previously shown that PACAP protects against several types of retinal injuries in vivo, including retinal ischemia, glutamate-induced excitotoxicity, UV A-induced lesion, and diabetic retinopathy. We have also shown that PACAP activates antiapoptotic pathways and inhibits proapoptotic signaling in retinal lesions in vivo. PACAP receptors have been identified on the retinal pigment epithelial cells and PACAP has been shown to inhibit interleukin secretion from pigment epithelial cells. It is not known, however, whether PACAP is protective in these cells. Human retinal pigment epithelial cells (ARPE-19 cell line) were exposed to in vitro oxidative stress by hydrogen peroxide. Cell survival was decreased in cells exposed to oxidative stress, which could be significantly and dose-dependently attenuated by 10 pM-1 μM PACAP treatment, as shown by MTT viability test. The protective effect of PACAP could be blocked by the receptor antagonist PACAP6-38. In addition, flow cytometry and JC-1 assay revealed that oxidative stress-induced apoptosis in retinal pigment epithelial cells could be decreased by PACAP treatment. In summary, these results show, for the first time, that PACAP is antiapoptotic in the retinal pigment epithelial cells.

Original languageEnglish
Pages (from-to)35-43
Number of pages9
JournalJournal of Molecular Neuroscience
Volume43
Issue number1
DOIs
Publication statusPublished - Jan 2011

Fingerprint

Pituitary Adenylate Cyclase-Activating Polypeptide
Retinal Pigments
Oxidative Stress
Epithelial Cells
Pituitary Adenylate Cyclase-Activating Polypeptide Receptors
Interleukins
Neuroprotective Agents
Diabetic Retinopathy
Neuropeptides
Hydrogen Peroxide
Glutamic Acid
Cell Survival
Flow Cytometry
Ischemia
Apoptosis
Cell Line

Keywords

  • Apoptosis
  • ARPE-19
  • Flow cytometry
  • Retinoprotection

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience

Cite this

Pituitary adenylate cyclase-activating polypeptide is protective against oxidative stress in human retinal pigment epithelial cells. / Mester, Laszlo; Kovacs, Krisztina; Rácz, B.; Solti, Izabella; Atlasz, Tamas; Szabadfi, K.; Tamás, A.; Reglodi, D.

In: Journal of Molecular Neuroscience, Vol. 43, No. 1, 01.2011, p. 35-43.

Research output: Contribution to journalArticle

@article{d6748710efe34aa69cf2b525267cd6cf,
title = "Pituitary adenylate cyclase-activating polypeptide is protective against oxidative stress in human retinal pigment epithelial cells",
abstract = "Pituitary adenylate cyclase-activating polypeptide (PACAP) is a neuropeptide with potent neurotrophic and neuroprotective effects. We have previously shown that PACAP protects against several types of retinal injuries in vivo, including retinal ischemia, glutamate-induced excitotoxicity, UV A-induced lesion, and diabetic retinopathy. We have also shown that PACAP activates antiapoptotic pathways and inhibits proapoptotic signaling in retinal lesions in vivo. PACAP receptors have been identified on the retinal pigment epithelial cells and PACAP has been shown to inhibit interleukin secretion from pigment epithelial cells. It is not known, however, whether PACAP is protective in these cells. Human retinal pigment epithelial cells (ARPE-19 cell line) were exposed to in vitro oxidative stress by hydrogen peroxide. Cell survival was decreased in cells exposed to oxidative stress, which could be significantly and dose-dependently attenuated by 10 pM-1 μM PACAP treatment, as shown by MTT viability test. The protective effect of PACAP could be blocked by the receptor antagonist PACAP6-38. In addition, flow cytometry and JC-1 assay revealed that oxidative stress-induced apoptosis in retinal pigment epithelial cells could be decreased by PACAP treatment. In summary, these results show, for the first time, that PACAP is antiapoptotic in the retinal pigment epithelial cells.",
keywords = "Apoptosis, ARPE-19, Flow cytometry, Retinoprotection",
author = "Laszlo Mester and Krisztina Kovacs and B. R{\'a}cz and Izabella Solti and Tamas Atlasz and K. Szabadfi and A. Tam{\'a}s and D. Reglodi",
year = "2011",
month = "1",
doi = "10.1007/s12031-010-9427-9",
language = "English",
volume = "43",
pages = "35--43",
journal = "Journal of Molecular Neuroscience",
issn = "0895-8696",
publisher = "Humana Press",
number = "1",

}

TY - JOUR

T1 - Pituitary adenylate cyclase-activating polypeptide is protective against oxidative stress in human retinal pigment epithelial cells

AU - Mester, Laszlo

AU - Kovacs, Krisztina

AU - Rácz, B.

AU - Solti, Izabella

AU - Atlasz, Tamas

AU - Szabadfi, K.

AU - Tamás, A.

AU - Reglodi, D.

PY - 2011/1

Y1 - 2011/1

N2 - Pituitary adenylate cyclase-activating polypeptide (PACAP) is a neuropeptide with potent neurotrophic and neuroprotective effects. We have previously shown that PACAP protects against several types of retinal injuries in vivo, including retinal ischemia, glutamate-induced excitotoxicity, UV A-induced lesion, and diabetic retinopathy. We have also shown that PACAP activates antiapoptotic pathways and inhibits proapoptotic signaling in retinal lesions in vivo. PACAP receptors have been identified on the retinal pigment epithelial cells and PACAP has been shown to inhibit interleukin secretion from pigment epithelial cells. It is not known, however, whether PACAP is protective in these cells. Human retinal pigment epithelial cells (ARPE-19 cell line) were exposed to in vitro oxidative stress by hydrogen peroxide. Cell survival was decreased in cells exposed to oxidative stress, which could be significantly and dose-dependently attenuated by 10 pM-1 μM PACAP treatment, as shown by MTT viability test. The protective effect of PACAP could be blocked by the receptor antagonist PACAP6-38. In addition, flow cytometry and JC-1 assay revealed that oxidative stress-induced apoptosis in retinal pigment epithelial cells could be decreased by PACAP treatment. In summary, these results show, for the first time, that PACAP is antiapoptotic in the retinal pigment epithelial cells.

AB - Pituitary adenylate cyclase-activating polypeptide (PACAP) is a neuropeptide with potent neurotrophic and neuroprotective effects. We have previously shown that PACAP protects against several types of retinal injuries in vivo, including retinal ischemia, glutamate-induced excitotoxicity, UV A-induced lesion, and diabetic retinopathy. We have also shown that PACAP activates antiapoptotic pathways and inhibits proapoptotic signaling in retinal lesions in vivo. PACAP receptors have been identified on the retinal pigment epithelial cells and PACAP has been shown to inhibit interleukin secretion from pigment epithelial cells. It is not known, however, whether PACAP is protective in these cells. Human retinal pigment epithelial cells (ARPE-19 cell line) were exposed to in vitro oxidative stress by hydrogen peroxide. Cell survival was decreased in cells exposed to oxidative stress, which could be significantly and dose-dependently attenuated by 10 pM-1 μM PACAP treatment, as shown by MTT viability test. The protective effect of PACAP could be blocked by the receptor antagonist PACAP6-38. In addition, flow cytometry and JC-1 assay revealed that oxidative stress-induced apoptosis in retinal pigment epithelial cells could be decreased by PACAP treatment. In summary, these results show, for the first time, that PACAP is antiapoptotic in the retinal pigment epithelial cells.

KW - Apoptosis

KW - ARPE-19

KW - Flow cytometry

KW - Retinoprotection

UR - http://www.scopus.com/inward/record.url?scp=79951581853&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951581853&partnerID=8YFLogxK

U2 - 10.1007/s12031-010-9427-9

DO - 10.1007/s12031-010-9427-9

M3 - Article

C2 - 20645022

AN - SCOPUS:79951581853

VL - 43

SP - 35

EP - 43

JO - Journal of Molecular Neuroscience

JF - Journal of Molecular Neuroscience

SN - 0895-8696

IS - 1

ER -